| 
Citations
 | 
   web
Swarner, R. (1999). Narcan : not a silver bullet. Harm Reduction Communication, (9), 6.
Toggle visibility
Lowe, K. (2005). Risky injection behaviors are established at onset of injection drug use. The JHU Gazette, 34(28; 04.04.2005), 2.
Toggle visibility
Mattick, R. P., & Hall, W. (1996). Are detoxification programmes effective? The Lancet, 347, 97–100.
Toggle visibility
O'Brien, C. P., & McLellan, T. (1996). Myths about the treatment of addiction. The Lancet, 347, 237–240.
Toggle visibility
Nutt, D. J. (1996). Addiction : brain mechanisms and their treatment implications. The Lancet, 347, 31–36.
Toggle visibility
Hadziyannis, S. J., Sette, H., Morgan, T. R., Vijayan, B., Diago, M., Marcellin, P., et al. (2004). Peginterfreon-α2a and ribavirin combination therapy in chronic hepatitis C : a randomized study of treatment duration and ribavirin dose. Annals of internal medecine, 140(5; 02.03.2004), 346–357.
Toggle visibility
Llosa, T. (1995). Cocalization : the standard low dose of oral cocaine used for treatment of cocaine dependence. Journal of chemical addictions, 6(1; 05/1995), 16.
Toggle visibility
European monitoring Centre for Drugs and Drug Addiction. (2008). 8 March : international women's day. Range of measures needed to monitor and reduce drug-facilitated sexual assault, (1; 07.03.2008), 2.
Toggle visibility
Gmel, G., Gaume, J., Faouzi, M., Kulling, J. - P., & Daeppen, J. - B. (2008). Who drinks most of the total alcohol in young men : risky single occasion drinking as normative behaviour. Alcohol and alcoholism : international journal of the Medical Council on Alcohol, 43(6; 22.08.2008), 692–697.
Toggle visibility
U.S. Centers for Disease Control and Prevention. (2003). HIV makes hepatitis B significantly more lethal. CDC HIV/Hepatitis/STD/TB prevention news update, (10.01.2003), 1.
Toggle visibility